Efficacy and Safety of Danoprevir/r + PR 12week Triple Therapy in Treatment Naive Non-Cirrhotic G1 CHC China III
Clinical trial NCT03020082 · COMPLETED
Trial details
- NCT number
- NCT03020082
- Sponsor
- Ascletis Pharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2017-05-01
- Enrollment
- 141
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.